159 related articles for article (PubMed ID: 1972620)
1. Synthesis of a nitric oxide-like factor from L-arginine by rat serosal mast cells: stimulation of guanylate cyclase and inhibition of platelet aggregation.
Salvemini D; Masini E; Anggard E; Mannaioni PF; Vane J
Biochem Biophys Res Commun; 1990 Jun; 169(2):596-601. PubMed ID: 1972620
[TBL] [Abstract][Full Text] [Related]
2. Rat mast cells synthesize a nitric oxide like-factor which modulates the release of histamine.
Masini E; Salvemini D; Pistelli A; Mannaioni PF; Vane JR
Agents Actions; 1991 May; 33(1-2):61-3. PubMed ID: 1716838
[TBL] [Abstract][Full Text] [Related]
3. Mast cells as a source of superoxide anions and nitric oxide-like factor: relevance to histamine release.
Mannaioni PF; Masini E; Pistelli A; Salvemini D; Vane JR
Int J Tissue React; 1991; 13(6):271-8. PubMed ID: 1726322
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase.
Mollace V; Salvemini D; Anggard E; Vane J
Br J Pharmacol; 1991 Nov; 104(3):633-8. PubMed ID: 1724627
[TBL] [Abstract][Full Text] [Related]
5. Cultured astrocytoma cells inhibit platelet aggregation by releasing a nitric oxide-like factor.
Mollace V; Salvemini D; Anggård E; Vane J
Biochem Biophys Res Commun; 1990 Oct; 172(2):564-9. PubMed ID: 2241954
[TBL] [Abstract][Full Text] [Related]
6. Impairment of the L-arginine-nitric oxide pathway in mast cells from spontaneously hypertensive rats.
Masini E; Mannaioni PF; Pistelli A; Salvemini D; Vane J
Biochem Biophys Res Commun; 1991 Jun; 177(3):1178-82. PubMed ID: 1711845
[TBL] [Abstract][Full Text] [Related]
7. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.
Radomski MW; Palmer RM; Moncada S
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5193-7. PubMed ID: 1695013
[TBL] [Abstract][Full Text] [Related]
8. Platelet inhibition by an L-arginine-derived substance released by IL-1 beta-treated vascular smooth muscle cells.
Durante W; Schini VB; Scott-Burden T; Junquero DC; Kroll MH; Vanhoutte PM; Schafer AI
Am J Physiol; 1991 Dec; 261(6 Pt 2):H2024-30. PubMed ID: 1661096
[TBL] [Abstract][Full Text] [Related]
9. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor.
Salvemini D; de Nucci G; Gryglewski RJ; Vane JR
Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6328-32. PubMed ID: 2548208
[TBL] [Abstract][Full Text] [Related]
10. Studies on the importance of the proposed release of nitric oxide from platelets.
Mollace V; Salvemini D; Vane J
Thromb Res; 1991 Dec; 64(5):533-42. PubMed ID: 1725563
[TBL] [Abstract][Full Text] [Related]
11. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: blockade of aggregation and secretion by an aspirin-insensitive mechanism.
Broekman MJ; Eiroa AM; Marcus AJ
Blood; 1991 Aug; 78(4):1033-40. PubMed ID: 1868238
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism.
Marsden PA; Ballermann BJ
J Exp Med; 1990 Dec; 172(6):1843-52. PubMed ID: 1979590
[TBL] [Abstract][Full Text] [Related]
14. Cultured astrocytoma cells generate a nitric oxide-like factor from endogenous L-arginine and glyceryl trinitrate: effect of E. coli lipopolysaccharide.
Salvemini D; Mollace V; Pistelli A; Anggård E; Vane J
Br J Pharmacol; 1992 Aug; 106(4):931-6. PubMed ID: 1327394
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide.
Boulanger C; Schini VB; Moncada S; Vanhoutte PM
Br J Pharmacol; 1990 Sep; 101(1):152-6. PubMed ID: 2178013
[TBL] [Abstract][Full Text] [Related]
16. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase.
Knowles RG; Palacios M; Palmer RM; Moncada S
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5159-62. PubMed ID: 2567995
[TBL] [Abstract][Full Text] [Related]
17. Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin.
Fleming I; Julou-Schaeffer G; Gray GA; Parratt JR; Stoclet JC
Br J Pharmacol; 1991 May; 103(1):1047-52. PubMed ID: 1678981
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase.
Aguila MC
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):782-6. PubMed ID: 7904758
[TBL] [Abstract][Full Text] [Related]
19. L-arginine stimulates cyclic guanosine 3',5'-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: evidence for L-arginine:nitric oxide synthase.
Laychock SG; Modica ME; Cavanaugh CT
Endocrinology; 1991 Dec; 129(6):3043-52. PubMed ID: 1683279
[TBL] [Abstract][Full Text] [Related]
20. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
Yu SM; Kuo SC
Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
